儿科和成人之间人类口腔桃体的代谢特征的差异
Seokhwan Lee1, Seonghye Kim2, Sung-Dong Kim3
1Department of Otorhinolaryngology, Inje University Haeundae Paik Hospital, Busan, Republic of Korea.
PloS one
|July 31, 2023
概括
宫桃体 (PT) 显示与年龄相关的代谢变化. 葡萄糖随着年龄的增长而增加,而甘氨酸和其他代谢物则减少,这表明成人免疫代谢活性降低.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢学 代谢学 代谢学
- 人体生理学 人体生理学
背景情况:
- 宫桃体 (PT) 是空气和饮食病原体的关键免疫器官.
- 之前的研究集中在PT组织学和免疫学上,而不是其代谢概况.
- 了解PT代谢对于免疫反应的洞察至关重要.
研究的目的:
- 为了研究人类 palatine 桃体的代谢概况.
- 为了确定与 palatine 桃体的年龄相关的代谢差异.
主要方法:
- 使用了高分辨率的神奇角度旋转核磁共振光谱法 (HR-MAS NMR).
- 对35个儿科和28个成人人口腔桃体样本进行了代谢分析.
- 用部分相关性分析来评估代谢物与年龄之间的关系.
主要成果:
- 在口腔桃体组织中发现了36种代谢物.
- 10种代谢物的水平在儿科和成人样本之间有显著差异.
- 葡萄糖水平随着年龄的增长而增加,而甘氨酸,胆,甲胺和甲酸盐水平则下降.
结论:
- 代谢分析显示,成人口腔桃体的免疫代谢活性下降.
- 鉴定了 palatine 桃体中的年龄相关的代谢变化.
- 这些发现为未来桃体相关的代谢学研究提供了基础.
相关概念视频
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...


